Searched for
CIPLA EBITDA MARGIN
Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
Strong revenue growth fails to shield India Inc margins in March quarterCorporate India's March 2026 quarter results showed a mixed performance. While revenues grew strongly, input cost inflation and a weaker ru...
Cipla shares rally 8% despite 55% YoY slump in Q4 profit. Why Citi, Nuvama, other brokerages hiked targetCipla shares surged on Thursday, extending gains to nearly 11% in two sessions, after several brokerages turned bullish on the stock despit...
Cipla Q4 Results: Profit falls 55% YoY to Rs 555 crore; co declares Rs 13/sh dividendCipla Ltd announced a significant 55% year-on-year drop in its consolidated net profit for the fourth quarter, reaching Rs 555 crore. This ...
Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
Cipla shares rally 6% in 2 days as Q1 results impress; brokerages raise target up to Rs 1,875Cipla shares: Following the earnings announcement, several brokerage firms revised their target price for the stock, with some estimates re...
Cipla Q3 preview: Up to 7% YoY uptick seen in revenue. Margins to fall on a YoY and sequential basisCipla's Q3FY25 revenue is expected to grow 3.1-7%, with profit estimates ranging from a 2.2% decline to 14% growth. Brokerages have differi...
Cipla Q2 results preview: 3-6% revenue uptick seen, net profit may rise by up to 5.7%Cipla is set to report a 3-6% revenue growth for the September quarter, as forecasted by four brokerages. The earnings for Q2FY25 will be a...
Cipla's North America business revenue hits record high in Q1 at $250 millionCipla's North American business achieved a record $250 million revenue in Q1 FY25, a 13% year-on-year growth. The company's branded prescri...
Cipla Q4 Results: Net profit jumps 79% YoY to Rs 939 crore on strong sales momentumCipla's North America sales, which constitute primarily US, grew 11.8% YoY to Rs 1875 crore driven by key products Lanreotide (used for tre...
Cipla Q4 Results Preview: Profit may rise up to 71% YoY on healthy operationsCipla Q4 Results Preview: As per the combined projections of four brokerages, there's a possibility of the net profit for the fourth quarte...
Cipla expects record 24 per cent Ebitda margin in FY24"We enter reverse seasonalist in our India business. The fourth quarter has always been the lowest, so that impacts our margins," Umang Voh...
Cipla shares jump 9% after Q1 profit soars 45% YoY to Rs 996 crore. Should you buy, sell or hold?In morning session, the scrip was trading 8.5% higher at Rs 1.160 on BSE. Meanwhile, in the last one year, it has surged 19%.
Cipla Q1 Results: Net profit jumps 45% YoY, to end FY24 with 23.5% EBITDA marginsCipla expects to finish FY24 with 23-23.5% EBITDA margins and more than 10% revenue growth. Robust sales growth in the US, India, and South...
Hot Stocks: Brokerages on Bajaj Auto, Dr Reddy’s Laboratories, Tata Motors and Cipla post Q3 resultsEBITDA margin improved by 176 bps YoY to 24.2% despite soft Revlimid sales, mainly driven by an improvement in the mix. The net profit grew...
Maruti, IHCL, Godrej Consumer are among Jefferies' top picksJefferies said the company's margins could jump to 31-32% for FY24-25 against 13% in FY22. "During Covid, IHCL has deployed several measure...
Cipla jumps 7% on profit push, but brokerages cut target priceThe company on Tuesday posted Q4 profit of Rs 179 crore ($26.24 million) against a loss of Rs 61.79 crore last year.
Brokerages slash target price on Cipla, CLSA downgrades to underperformCipla reported a consolidated net loss of Rs 61.79 crore for the quarter ended March.
Cipla surprises Street with 10% jump in Q1 profitCipla has posted a 10% increase in profit after tax for the quarter ended June 30 at Rs 485 crore against Rs 440 cr in the year-ago period.
What to expect from Cipla Q1 numbers due on FridayAlthough, Cipla has remained flat so far in the year 2013, analysts feel that the stock has the potential to move higher in the coming quar...